Glioblastoma is an aggressive and often deadly cancer of the brain. Understanding it is vital to improving patient outcomes. In a new study published in Nature Genetics, a group in Cornell University has been sequencing genes to understand which ones are switched on by the tumours. To learn more, Adam Murphy spoke to Charles Danko, of the Baker Institute for Animal Health and the Cornell College of Veterinary Medicine.